ABSTRACT
Gallic acid (GA) has been found by a large number of studies to have pharmacological effects such as antioxidant and anti-inflammatory properties. However, the underlying therapeutic mechanisms are not fully understood.. Studies have shown that altering the intestinal flora affects host metabolism and effectively mediates the development of synovitis. The aim of this study was to explore the pharmacological effects of GA in the treatment of synovial inflammation and anti-synovial fibrosis in knee osteoarthritis (KOA) and the underlying mechanisms by macrogenomics combined with off-target metabolomics. We established a synovitis model via in vivo and in vitro experiments to observe the effect of GA intervention on synovitis. Moreover, we collected serum and feces from rats and analyzed the changes in intestinal flora by macro-genome sequencing and the changes in metabolites in the serum by untargeted metabolomics. We found that GA reduced the levels of IL-1ß, IL-6, and TNF-α, and decreased the protein expression levels of α-SMA, TGF-ß, and Collagen I in synovial tissues and cells, and the composition and function of the intestinal flora were similarly altered. Combined with macrogenomic pathway enrichment analysis and metabolic pathway enrichment analysis, these findings revealed that GA impacts Bacteroidia and Muribaculaceae abundance, and via the following metabolic pathways: sphingolipid metabolism, glycerophospholipid metabolism, and arginine biology.to ameliorate synovial inflammation and fibrosis in KOA. The therapeutic effect of GA on KOA synovitis and fibrosis is partly attributed to the alleviation of metabolic disorder and the rebalancing of the intestinal flora. These results provides a rationale for the therapeutic application of GA in the treatment of synovitis.
Subject(s)
Fibrosis , Gallic Acid , Gastrointestinal Microbiome , Rats, Sprague-Dawley , Animals , Gallic Acid/pharmacology , Gallic Acid/therapeutic use , Gastrointestinal Microbiome/drug effects , Male , Rats , Synovitis/drug therapy , Synovitis/pathology , Synovitis/metabolism , Anti-Inflammatory Agents/pharmacology , Anti-Inflammatory Agents/therapeutic use , Synovial Membrane/drug effects , Synovial Membrane/metabolism , Disease Models, Animal , MetabolomicsABSTRACT
This study aimed to investigate whether the beneficial effects of PCA on chondrocyte senescence are mediated through the regulation of mitophagy. Chondrocyte senescence plays a significant role in the development and progression of knee osteoarthritis (OA). The compound protocatechuic aldehyde (PCA), which is abundant in the roots of Salvia miltiorrhiza, has been reported to have antioxidant properties and the ability to protect against cellular senescence. To achieve this goal, a destabilization of the medial meniscus (DMM)-induced mouse OA model and a lipopolysaccharide (LPS)-induced chondrocyte senescence model were used, in combination with PINK1 gene knockdown or overexpression. After treatment with PCA, cellular senescence was assessed using Senescence-Associated ß-Galactosidase (SA-ß-Gal) staining, DNA damage was evaluated using Hosphorylation of the Ser-139 (γH2AX) staining, reactive oxygen species (ROS) levels were measured using Dichlorodihydrofluorescein diacetate (DCFH-DA) staining, mitochondrial membrane potential was determined using a 5,5',6,6'-TETRACHLORO-1,1',3,3'-*. TETRAETHYBENZIMIDA (JC-1) kit, and mitochondrial autophagy was examined using Mitophagy staining. Western blot analysis was also performed to detect changes in senescence-related proteins, PINK1/Parkin pathway proteins, and mitophagy-related proteins. Our results demonstrated that PCA effectively reduced chondrocyte senescence, increased the mitochondrial membrane potential, facilitated mitochondrial autophagy, and upregulated the PINK1/Parkin pathway. Furthermore, silencing PINK1 weakened the protective effects of PCA, whereas PINK1 overexpression enhanced the effects of PCA on LPS-induced chondrocytes. PCA attenuates chondrocyte senescence by regulating PINK1/Parkin-mediated mitochondrial autophagy, ultimately reducing cartilage degeneration.
Subject(s)
Benzaldehydes , Catechols , Cellular Senescence , Chondrocytes , Mitophagy , Protein Kinases , Ubiquitin-Protein Ligases , Chondrocytes/drug effects , Chondrocytes/metabolism , Chondrocytes/pathology , Animals , Cellular Senescence/drug effects , Ubiquitin-Protein Ligases/metabolism , Ubiquitin-Protein Ligases/genetics , Mitophagy/drug effects , Protein Kinases/metabolism , Mice , Catechols/pharmacology , Benzaldehydes/pharmacology , Reactive Oxygen Species/metabolism , Mitochondria/drug effects , Mitochondria/metabolism , Mitochondria/pathology , Male , Mice, Inbred C57BL , Autophagy/drug effects , Membrane Potential, Mitochondrial/drug effects , Osteoarthritis, Knee/pathology , Osteoarthritis, Knee/metabolism , Osteoarthritis, Knee/drug therapyABSTRACT
Photoelectrochemical (PEC) water splitting has been widely investigated for solar-to-hydrogen conversion. However, issues like high charge recombination rate and slow surface water oxidation kinetics severely hinder its (PEC) conversion efficiency. Herein, we constructed MOF-derived CoOOH cocatalyst on BiVO4 photoanode, using a feasible electrochemical activation strategy. The BiVO4-based photoanode obtained shows a high photocurrent density of 3.15 mA/cm2 at 1.23 VRHE and low onset potential. Detailed experiments and theoretical calculations show that during the activation of CoZn-MOFs, there was a partial breakage of 2-methylimidazole (mIM) linker, an increase in the oxidation state of Cobalt ion (Co), and increased O2-. The high PEC performance is mainly attributed to the MOF-derived CoOOH, which provides rich active sites for hole extraction and reduces the overpotential for oxygen evolution reaction. Furthermore, when CoZnNiFe-LDHs were decorated on BiVO4 using the ions exchange method, the photocurrent density of BiVO4/CoZnNiFe-LDHs photoanode got to 4.0 mA/cm2 at 1.23 VRHE, accompanied with high stability. This study provides insights into understanding the key role played by the structural transformation of MOF cocatalyst in PEC water splitting processes.